Credit Agricole’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Credit Agricole’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-36	Closed	-$18	–	1347
2024 Q4	$18	Hold	36	–	–	﹤0.01%	1273
2024 Q3	$134	Buy	+36	New	+$172	﹤0.01%	1271

Other funds holding EGRX

SLG

Stanley-Laman Group Berwyn, Pennsylvania $984M AUM 72.08% 1-Year Est. Return

AIC

Archer Investment Corporation Carmel, Indiana $522M AUM 26.29% 1-Year Est. Return

Credit Agricole's EGRX Position: Q1 2025 in Review

Credit Agricole sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q1 2025, closing a stake of 36 shares — an estimated $18 sold.

Credit Agricole first reported a position in EGRX in Q3 2024 and held it in 2 quarters. The position peaked at $134 in Q3 2024. 2 funds tracked by Wall St. Rank hold EGRX as of Q1 2025.

Credit Agricole reported no remaining Eagle Pharmaceuticals, Inc. position as of Q1 2025 after selling out during the quarter.
Credit Agricole sold 36 Eagle Pharmaceuticals, Inc. shares in Q1 2025, an estimated $18.
Credit Agricole first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2024 and held it in 2 quarters.
Credit Agricole's Eagle Pharmaceuticals, Inc. position peaked at $134 in Q3 2024.
2 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2025.

Based on Credit Agricole's 13F filing for Q1 2025, filed 14 May 2025.